Szajek, Anita Y
Chess, Edward
Johansen, Kristian
Gratzl, Gyöngyi
Gray, Elaine
Keire, David
Linhardt, Robert J
Liu, Jian
Morris, Tina
Mulloy, Barbara
Nasr, Moheb
Shriver, Zachary
Torralba, Pearle
Viskov, Christian
Williams, Roger
Woodcock, Janet
Workman, Wesley
Al-Hakim, Ali
Article History
First Online: 9 June 2016
Competing interests
: A.Y.S., K.J., G.G., E.G., T.M., B.M., M.N., R.W., J.W., D.K. and A. A.-H. declare no competing financial interests. R.J.L. declares competing interest in the form of funding derived from the NIH in the form of research grants in the area of heparin analysis and regularly consults on heparin analysis. J.L. declares competing interest in the form of funding derived from the NIH and FDA in the form of research grants in the area of heparin. J.L. is a founder of Glycan Therapeutics, LLC. C.V. is an employee of Sanofi and has financial interest in the company. E.K.C. was a stockholder and employee of Baxter Healthcare Corporation during the completion of this work. W.E.W. is an employee of Pfizer and has financial interest in the company.